CYP2D6 and benign prostatic hyperplasia: This point of view is reinforced bythe fact that the reference drug for BPH treatment, tamsulosin, is not only extensivelymetabolized by CYP2D6 but also by CYP3A4 (32),the major source of drug-drug interaction.